Evidence map›Paper›PMID 32546576›Full record

ArticleCancer discovery2020

Lineage Reversion Drives WNT Independence in Intestinal Cancer.

Teng Han, Sukanya Goswami, Yang Hu, Fanying Tang, Maria Paz Zafra, Charles Murphy, Zhen Cao, John T Poirier, Ekta Khurana, Olivier Elemento and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer discovery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Targeting the Hippo pathway in cancer.Nature reviews. Drug discovery · 2025
    Review
  8. Review
  9. Embryonic Signaling Pathways Shape Colorectal Cancer Subtypes: Linking Gut Development to Tumor Biology.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Teng HanSandra and Edward Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine, New York, New York.
Sukanya GoswamiSandra and Edward Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine, New York, New York.
Yang HuDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, New York.ORCID https://orcid.org/0000-0002-6348-874X
Fanying TangWeill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, New York.
Maria Paz ZafraSandra and Edward Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine, New York, New York.
Charles MurphySandra and Edward Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine, New York, New York.
Zhen CaoWeill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, New York.ORCID https://orcid.org/0000-0002-8120-9951
John T PoirierPerlmutter Cancer Center, New York University Langone Health, New York, New York.ORCID https://orcid.org/0000-0001-9795-5644
Ekta KhuranaDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, New York.ORCID https://orcid.org/0000-0002-4351-7566
Olivier ElementoDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, New York.
Jaclyn F HechtmanDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Karuna GaneshMolecular Pharmacology Program and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Rona YaegerDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Lukas E DowSandra and Edward Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine, New York, New York. lud2005@med.cornell.edu.ORCID https://orcid.org/0000-0001-7048-1418
Cornell University · USMemorial Sloan Kettering Cancer Center · USNYU Langone Health · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Progression, response, and resistance of RSPO fusion colorectal cancerR01CA222517 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI DOW, LUKAS EDWARD · 2018 to 2022
$1.9M
Molecular and Translational Oncology ResearchT32CA203702 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI BLENIS, JOHN, GIANNAKAKOU, PARASKEVI · 2017 to 2021
$1.4M
Investigating L1CAM-dependent stem cell regeneration in metastasisK08CA230213 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI GANESH, KARUNA · 2018 to 2022
$1.3M
NCI NIH HHS K08 CA230213NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA222517NCI NIH HHS T32 CA203702
6 · The paper itself

Abstract

The WNT pathway is a fundamental regulator of intestinal homeostasis, and hyperactivation of WNT signaling is the major oncogenic driver in colorectal cancer. To date, there are no described mechanisms that bypass WNT dependence in intestinal tumors. Here, we show that although WNT suppression blocks tumor growth in most organoid and

Indexed as

AnimalsCell Line, TumorHumansIntestinal NeoplasmsMiceWnt Signaling Pathway

Identifiers

PMID32546576
PMCPMC7541594
OpenAlexW3034286433

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.